A new sub-study suggests that using a sirolimus-eluting balloon (SEB), a drug-coated balloon, can reduce the number of stents ...

A new sub-study suggests that using a sirolimus-eluting balloon (SEB), a drug-coated balloon, can reduce the number of stents a patient may need, making it a safe and effective way to treat certain ...

Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...

Gore & Associates announced new 12-month findings from the global GORE VIABAHN FORTEGRA Venous Stent IVC trial, which evaluat ...

LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group"; stock code: ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has applied for CE Mark approval for its Liverty TIPS Stent Graft to advance treatment options for portal ...

Real-world study of the iVascular Restorer BMS in iliac artery lesions was composed of 200 patients, 34% with TASC C and D lesions. 1-year results confirm safety and efficacy across TASC A to D ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has received CE Mark approval in the European Union for its Revello Vascular Covered Stent. With this approval, BD ...

"The CE Marking of the Revello™ Stent is a significant advancement towards helping physicians treating complex iliac artery disease," said Rima Alameddine, worldwide president, BD Interventional – ...

Iliac artery endofibrosis was recently deemed by top medics as an “occupational hazard” of pro cycling. But despite being considered one of the inescapable risks of the sport, it remains one of the ...